Journal of Applied Physiology Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

J Appl Physiol (January 10, 2003). doi:10.1152/japplphysiol.00575.2002
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
94/5/1836    most recent
00575.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanaoka, M.
Right arrow Articles by Kubo, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanaoka, M.
Right arrow Articles by Kubo, K.
Submitted on July 1, 2002
Accepted on January 2, 2003

Vascular endothelial growth factor in patients with high-altitude pulmonary edema

Masayuki Hanaoka1*, Yunden Droma1, Atsuhiko Naramoto1, Takayuki Honda2, Toshio Kobayashi1, and Keishi Kubo1

1 First Department of Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan
2 Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

* To whom correspondence should be addressed. E-mail: masayuki{at}hsp.md.shinshu-u.ac.jp.

To examine the role of vascular endothelial growth factor (VEGF) in the pathogenesis of high-altitude pulmonary edema (HAPE), we measured the concentrations of VEGF in venous serum and bronchoalveolar lavage fluid (BALF) in patients with HAPE and healthy volunteers. The VEGF in venous serum of the patients was normal at admission while significantly increased at recovery. Similarly, the VEGF in BALF of the patients was increased at recovery compared to that at admission, but both at admission and recovery were significantly lower than that of the controls, respectively. The present finding suggests that VEGF probably is destroyed in the lung of HAPE and it appears less likely to have a critical part in the pathogenesis of HAPE, but rather an important role in the repair process for the impaired cell layer.




This article has been cited by other articles:


Home page
 ThoraxHome page
R Zhai, M N Gong, W Zhou, T B Thompson, P Kraft, L Su, and D C Christiani
Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS
Thorax, August 1, 2007; 62(8): 718 - 722.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A R L Medford and A B Millar
Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?
Thorax, July 1, 2006; 61(7): 621 - 626.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
L. B. Ware, R. J. Kaner, R. G. Crystal, R. Schane, N. N. Trivedi, D. McAuley, and M. A. Matthay
VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema
Eur. Respir. J., July 1, 2005; 26(1): 101 - 105.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. Pun
The Physiologic Basis of High-Altitude Diseases
Ann Intern Med, April 5, 2005; 142(7): 591 - 592.
[Full Text] [PDF]

Home page
 ThoraxHome page
A R L Medford, L J Keen, J L Bidwell, and A B Millar
Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome
Thorax, March 1, 2005; 60(3): 244 - 248.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1966 by the American Physiological Society.